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EMBRYONIC STEM CELLS, INTELLECTUAL
PROPERTY, AND PATENTS: ETHICAL CONCERNS
Samuel Packer, M.D. *

I.

INTRODUCTION

The ethical issues surrounding the research involving embryonic
stem cells can be traced back to the principles of Kant,' Mill,' Rawls, 3
and other philosophers. As with all ethical principles, they tend to be
absolute and vague. Thus, when society faces new technology, there is a
need for ethical analysis. Ethical analysis deals with dilemmas that occur
when the resolution to an issue brings into play two or more conflicting
principles. When discussing stem cell ethics, we must further accept that
an ethical analysis will include healthcare, research, and business, and
that each will have specific ethical concerns. Thus, we have the usual
social ethics of freedom-respect for the individual (Kant), respect for
the group (Mill), and for justice (Rawls); and we add the ethical issues of
medicine-autonomy, beneficence, non-maleficence, justice, and the
norms and values of religion and politics. It is worth noting that science
and the idea of progress emerged recently (sixteenth century) and that
"'[p]rogress involves a judgment of value' ....[and] there is inevitably
an ethical element .... [that] implies that. . . [it] flows in a desirable

* The Arthur and Arlene Levine Professor of Clinical Ophthalmology, New York
University School of Medicine; Chair, Ethics Committee North Shore University Hospital and Long
Island Jewish Medical Center.
1. See generally IMMANUEL KANT, FUNDAMENTAL PRINCIPLES OF THE METAPHYSIC OF
MORALS (Thomas K. Abbott trans., Liberal Arts Press 1949) (1785) (explaining moral principles by
asserting several different general principles regarding moral duties).
2. See generally JOHN STUART MILL, ON LIBERTY (Alburey Castell ed., Harlan Davidson,
Inc. 1947) (1859) (emphasizing that one of the critical elements of liberty is the freedom to express
one's own opinions).
3. See generally JOHN RAWLS, A THEORY OF JUSTICE (rev. ed. 1999) (1971) (discussing and
analyzing notions of justice).
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direction. ' 4 A basic understanding of the ethical principles involved in
the stem cell debates will not necessarily get us to socially acceptable
answers because of the pluralistic values that exist in society. For
example, even arguments based on deontology will differ, whether one
believes in a theological basis for analysis with the source being the will
or laws of God versus another monistic deontology, such as Kant's,
where acts are judged by their universalizability. 5 Thus, specifics, or
particulars, deserve attention, as does the consensus that will be needed
for the political process to achieve a socially acceptable solution that is
not just a pyrrhic victory for the strong. The need for ethical alignment,
as opposed to economic alignment, and preferably for the alignment of
both is the subject of this Article. The complexity is due to the many
stakeholders and the many areas, both ethical and non-ethical, that relate
to stem cell research. These include: national and international political
systems, legal systems, healthcare systems, research efforts that are both
government-supported and non-government-supported, various views of
different religious groups, and basic philosophical and ethical
understandings of when life begins and the dignity of life and who
decides and how to decide-to mention just a few of the specific areas
that require alignment.
How societies deal with the acquisition of new knowledge and the
processes that enable society to use this new knowledge speak to the
concern of social ethics-what kind of people are we? Are we good or
are we bad?
II.

ETHICS

A. Basics: Values andDilemmas
From the principles mentioned above, values are generated for
individuals and groups to function in an agreed manner. Since groups
evolve with different values and prioritize them differently depending on
the situation, dilemmas arise. Typical ethical values include respect for
life, law, freedom, and health. In healthcare, autonomy, beneficence, and

4.

Charles A. Beard, Introductionto J.B. BURY, THE IDEA OF PROGRESS: AN INQUIRY INTO

ITS ORIGIN AND GROWTH, at xxix (Dover Publ'ns, Inc. 1955) (1932) (quoting J.B. Bury, Darwinism
and History, reprintedin DARWIN AND MODERN SCIENCE-ESSAYS IN COMMEMORATION OF THE
CENTENARY OF THE BIRTH OF CHARLES DARWIN AND OF TE FIFTIETH ANNIVERSARY OF THE
PUBLICATION OF THE ORIGIN OF SPECIES 532 (A.C. Seward ed., 2007))
5. See Jonathan Haidt, The New Synthesis in Moral Psychology, 316 SCIENCE 998, 1001

(2007) (listing the different moral foundations upon which groups in society rely),
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justice are the expected norms. Society functions smoothly and its
citizens prosper when there is agreement as to social norms and these
social norms are prioritized fairly and consistently. Dilemmas occur
when individuals or groups feel that a particular value/norm is more
important than does another individual or group. For instance, with stem
cell research, the issue of when life begins or the definition of life may
be based on different values and not on some scientific definition. Thus,
there is a need for a dialogue that attempts to clarify these differences
and seek consensus. Fundamental questions may exist, such as whether a
society should have a theocracy or a democracy and, by extension,
whether a society can have both. The point is that the latter-that is, two
types of government, theocratic and democratic, in one society-seems
improbable, but having individuals or groups within a society differ
regarding religious versus secular beliefs seems likely. Since the latter is
probable, we need to understand the basis for disagreements and attempt
through understanding to allow for these debates to facilitate the making
of a consensus that allows society to prosper. Theocracies place more
moral value on respect for authority, loyalty, and spiritual purity, while
democracies
value harm and fairness among the other values mentioned
6
above.

The critical issues here are health and life. Some view research and
the creation of new knowledge as requiring acceptance by various
groups within society. Others view research as a responsibility of those
who create new knowledge-researchers. These ethical debates require
particulars to do any sort of reasonable analysis. A casuistic approach is
one that attempts to deal with specific situations and use ethics and
logic, but leads to action rather than analytic paralysis.7 Stem cell
research represents a new technology with important and unique
dilemmas that are added to the usual dilemmas presented by new
technology; specifically, there are the religious issues that relate to
definitions of life and respect for the sanctity of life. Thus, there is a
need for a basic agreement and consensus-not unanimity-as to what
defines life and personhood and when there is a soul. Here we must
address some basic philosophical questions and admit to the philosophy
upon which we are basing actions; for example, utilitarianism versus
individualism, liberalism versus conservatism, or other social and
political philosophies. Do we want more government or less
government? Do we want the answers to come from the marketplace or

6. Id.atI00fig.l.
7.

ALBERT R. JONSEN, THE NEW MEDICINE AND THE OLD ETHICS 55 (1990).
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from academia? Gaining economic alignment will be much easier than
gaining philosophical alignment, especially when one appreciates the
international scope of stem cell issues. It is important to recognize and
accept the fact that time is a factor in the feelings that society has about
new technology. A recent poll survey asked, among other questions,
whether "[i]t is morally acceptable to do medical research using stem
cells obtained from human embryos.",8 In 2002, fifty-two percent felt
that it was acceptable, and in 2008, sixty-two percent felt that it was
acceptable. 9 Other questions that related to moral values and religion
showed a significant change over the seven years.' 0
B. Professionalism:Medicine, Law, Religion, and Educators
Added to the complexity of analyzing the basic social-ethical
dilemmas, there are additional ethical areas that should be represented in
any discussion of stem cell research. These include the ethical precepts
of the professions. The "learned" professions of medicine, law, and
clergy have adopted the ethical principles of respect for autonomy,
beneficence, non-maleficence, and justice." The rationale that emerged
historically is critical to understand so that any trade-offs that occur
when analyzing an ethical dilemma are not simplified. These professions
were elevated from trades over thousands of years, primarily because
society felt that it would be better protected if these professions acted in
the best interests of citizens who were in vulnerable circumstances.
Those in need of healthcare, legal help, or religious guidance were felt to
be vulnerable, and therefore special privileges were granted to these
professions if they would act according to an agreed to social
covenant-that is, a contract. This fiduciary role for physicians, lawyers,
and clergy evolved legally with licensure, codes of ethics, and external
and internal mechanisms of compliance. Codes of ethics attempt to
insure the promises of the profession and seek consistency in behavior
that benefits society without acting as a trade guild.' 2 This fiduciary role
8. Charles M. Blow, Op-Ed., Americans Move to the Middle, N.Y. TIMES, July 26, 2008, at
A17.
9. Id.
10. Id.
11. See, e.g., Michael D. Bayles, The Professions, in ETHICAL ISSUES IN PROFESSIONAL LIFE
27-30 (Joan C. Callahan ed., 1988). But see Edmund Pellegrino, The Medical Professionas a Moral
Community, in PHYSICIAN AND PHILOSOPHER 208 (Roger J. Bulger & John P. McGovern eds.,
2001) (discussing the erosion of the medical profession as a moral community).
12. See Michael Davis, Thinking Like an Engineer: The Place of a Code of Ethics in the
Practiceof a Profession, 20 PHIL. & PUB. AFF. 150, 153-54 (1991) ("A code protects members of a
profession from certain consequences of competition.").
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may be looked at legally or ethically. Both views point to a
responsibility to act in the best interest of the vulnerable.
Although the "learned" professions were the first to attain social
status and license, other professions have recently sought and earned
similar status. This has required the fulfilling of the major tenets of a
profession, as opposed to a trade. The major characteristics of a
profession include: "First, a rather extensive training is
required .... Second, the training involves a significant intellectual
component ...[as] providing advice rather than things is a characteristic
feature
of the
professions.... Third,
the
trained
ability
provides ...services

important

to

the

organized

functioning

of

society.' 13 Thus, nurses, teachers, professors, engineers, and others have
attained social acceptance as professionals. The religious connections to
early medicine and the congruence of moral beliefs have been noted:
Non-Christian physicians in the ancient world and middle ages Egyptian, Hebrew, Moslem, Indian and Chinese - were also Members
of moral communities each with its own religious or quasireligious
binding force. What is remarkable is the congruence of ethical precepts
among physicians who held widely disparate world-views. This
suggests something intrinsic to the morality of medicine as a human
activity that in some way transcends culture, religion, and historical
era. But still, neither the Christian nor non-Christian physicians
explicitly developed the idea of a moral community with definitive
14
collective obligations to society ....
Therefore it is helpful to appreciate that religious differences did not
preclude the acceptance of the basic moral code of the professions. The
recent political decisions to restrict federal funding of stem cell research
in the United States did little to improve dialogue between the many
interested parties. The freedom of religious groups to lobby for their
views is accepted in a free society. However, the basic tenets of
American democracy are that the government will represent a pluralistic
society and not favor one group over another.t 5 The strong views
presented by President George W. Bush and echoed by Dr. Leon Kass,
the former Chair of the President's Bioethics Council, 16 need to be taken

13. Bayles, supranote 11, at 28.
14. Pellegrino, supranote 11, at 207 (footnote omitted).
15. See MICHAEL MANDELBAUM, DEMOCRACY'S GOOD NAME: THE RiSE AND RISKS OF THE
WORLD'S MOST POPULAR FORM OF GOVERNMENT 83 (2007).

16. The
President's
Council
on
Bioethics,
Leon
http://www.bioethics.gov/about/kass.html (last visited Feb. 28, 2009).
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as important but perhaps not representative.' 7 Kass's lecture reflects a
view that is the opposite of one that should represent a pluralistic society
or one that represents a democratic government. 18 The anti-science
rhetoric ignores the fact that "after stripping away the hyperbole, one
finds that it took a dedicated independent researcher, aided by desperate
patients, before a reluctant drug company delivered on the promise of its
proprietary product."' 9
As a profession, law has also promised society that it would act in
the individual's best interest and uphold its promises to society. In the
latter role, its practitioners serve individuals (clients, patients, and
research subjects) and groups (biomedical technology companies,
university research laboratories, etc.) and, as judges, act to uphold the
values within society. Whether these values include those moral values
that relate to the issues surrounding stem cell research remains uncertain.
Professor Derek Morgan states that, "[s]cientific citizenship requires that
law develop a moral vision and vocabulary so that we shape the moral
dimensions of the emergent bioeconomy. '' 20 This will place the courts in
the position to adjudicate, as well as possibly uphold regulations that
present moral dilemmas. One of the specific dilemmas is between the
value of choice (market-driven access) and the value of human dignity
(who decides when life begins).
It is not that choice is unimportant but that, as a value in the art of
medicine, it can come to be overvalued: knowing the price of
everything and the value of nothing, as Oscar Wilde observed, is the
hallmark of the cynic who degrades and devalues the potential and
possible roles and rotes of the doctor, who is becoming more and more
a partner to the scientific business enterprise in conjunction with the
scientist.2

17. See generally Leon R. Kass, Wriston Lecture of the Manhattan Institute for Policy
Research, Keeping Life Human: Science, Religion, and the Soul (Oct. 18, 2007), available at
http://www.manhattan-institute.org/htm/wl2007.htm (arguing that those within the scientific
community who seek to provide a purely scientific account for all aspects of human life threaten the
moral fabric of the nation).
18. See David DeGrazia, Moral Status, Human Identity, and Early Embryos: A Critique of the
President'sApproach, 34 J.L. MED. & ETHIcs 49, 56 (2006) (noting the opposing viewpoints on

cloning for biomedical research in society and the impact this strife has on policy-making).
19. MERRILL GOOZNER, THE $800 MILLION PILL: THE TRUTH BEHIND THE COST OF NEW
DRUGS 199 (2004).
20. Derek Morgan, The Problems and Possibilities in Regulating Technological Frontiers:
The Politics of the New Anxiety?, 15 J.L. & MED. 77, 79 (2007).

21.

Id.at 86.
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The progress of stem cell research warrants an early look, before
therapies emerge, at the ethical issues that may be critical. Hans Jonas
has called for "scientific futurology," and the legal system has called for
"lengthened foresight., 22 Some see health as representing a human
freedom, and therefore, choice might take precedent in analyzing any
legal restrictive regulation. The value of freedom may not fare well in an
ethical analysis where progress is looked upon as a more important
value. The latter would be supported by many, including researchers, the
bioeconomic interests in markets, and politics-including utilitarian
thinking, which emphasizes the greatest good for the greatest number.
Thus, moral reflection will be required at many levels and by many
stakeholders and stockholders. In addition, it is essential to consider the
pluralistic perspective due to different religious values and the political
influence of religious groups. This will require a respect for and
inclusion of the various religious moral perspectives on the stem cell
debate. This will include the values felt to be important with defining the
beginning of life and the conundrum presented with dignitarian
absolutist views, such as Kant and certain Catholic perspectives.2 3
III.

KNOWLEDGE, SCIENCE, TECHNOLOGY, AND PROGRESS

Stem cell research is not the first area of research to have ethical
concerns that overlap science and religion. The birth control pill and in
vitro fertilization preceded stem cell research with many of the same
ethical issues that some would argue still exist and are reemerging with
stem cell research.2 4 The stem cell "wars" bring to the table many of the
same opponents once again.25 The justification of government
intervention-as occurred with President George W. Bush's federal
restrictions on federal funding of stem cell research-has been

22. Id. at 85.
23. See KANT, supra note 1, at 45-46 ("Now I say: man and generally any rational being
exists as an end in himself, not merely as a means to be arbitrarily used by this or that will, but in all
his actions, whether they concern himself or other rational beings, must be always regarded at the
same time as an end.... Accordingly the practical imperative will be as follows: So act as to treat
humanity, whether in thine own person or in that of any other, in every case as an end withal, never
as means only."); see also Michael R. Prieur et al., Stem Cell Research in a Catholic Institution:Yes
orNo?, 16 KENNEDY INST. ETHICS J. 73, 74 (2006) (exploring whether Catholic healthcare facilities
could participate in stem cell research without running afoul of Catholic teachings regarding
conception and personhood).
24. See Debora Spar & Anna Harrington, Selling Stem Cell Science: How Markets Drive Law
Along the TechnologicalFrontier, 33 AM. J.L. & MED. 541, 542-43 (2007); see also EVE HEROLD,
STEM CELL WARS: INSIDE STORIES FROM THE FRONTLINES 31-32 (2006).

25.

See HEROLD, supra note 24, at 30-32.
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challenged, and several states have decided to fund stem cell research
because of the actions of the federal government.26 This may represent a
seismic shift in how medical research is done in the United States and
may cause a "Balkanization" of research. 27 It is important to recognize
that government officials are influenced by their personal religious
beliefs, as well as those of political supporters. In addition, commercial
interests in the potential business opportunities offered by any new
technology bring other players to the political table. In this way,
California formed an agency to promote stem cell research and to have
the citizens of California be the financial beneficiaries of any
commercial profit.2 This creates new ethical conundrums for other
states and for other societies. Also, it seems intuitive that an unintended
economic consequence of restricting research will be that other countries
take advantage of the opportunity. As has been noted, "even in areas of
strong moral opposition, science can often develop in the shadow of the
law, with the market eventually
compelling both moral concerns and
29
legal prohibitions to decline.,
The Bayh-Dole University and Small Business Patent Procedures
Act ("Bayh-Dole Act") 30 and the Stevenson-Wydler Technology
Innovation Act ("Stevenson-Wydler Act") 3 1 attempt to have society
benefit from research that receives government funding-that is, they
attempt to increase technology transfer.32 This has had good and bad
consequences, often depending on one's social and political views. With
the desire to have the commercialization of new technology occur more

26. See DeGrazia, supra note 18, at 49 ("The President... expressed his strong opposition to
any type of human cloning, and announced a policy of restricting federal funds for embryonic stem
cell research .. ");
see also Cal. Inst. for Regenerative Med., About CIRM, http://cirm.ca.gov (last
visited Feb. 27, 2009) [hereinafter CIRM] (noting the passage of Proposition 71 in California, which
provided billions of dollars in funding for stem cell research); New York State Stem Cell Science,
http://stemcell.ny.gov (last visited Feb. 27, 2009) [hereinafter NYSTEM] (describing similar
legislation in New York). President Bush's stance on stem cell research has received a fresh gloss
by President Barack Obama. Exec. Order No. 13,505, 74 Fed. Reg. 10,667 (Mar. 9, 2009).
27. See James W. Fossett et al., Federalism & Bioethics: States and Moral Pluralism, 37
HASTINGS CENTER REP. 24, 34 (2007) (noting that the "moral and political complexity" of
bioethical issues will make establishing national standards difficult and thus most policy decisions
will remain with the states).
28. CIRM, supra note 26.
29. Spar & Harrington, supranote 24, at 543.
30. University and Small Business Patent Procedures Act of 1980, Pub. L. No. 96-517, § 6(a),
94 Stat. 3019 (1980) (codified as amended at 35 U.S.C. §§ 200-212 (2000)).
31. Technology Innovation Act of 1980, 15 U.S.C. §§ 3701-3715 (2006).
32. See Arti K. Rai & Rebecca S. Eisenberg, Bayh-Dole Reform and the Progress of
Biomedicine, 66 LAW & CONTEMP. PROBS. 289, 290 (2003) (explaining that the legislative goal of
these two Acts was to "promote widespread utilization of federally-sponsored inventions").
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efficiently, the result was an enormous increase of patents from medical
schools and a concurrent significant increase in expenditures to establish
administrative offices to handle these efforts.33 As Part IV will discuss,
the negative effects from commercializing universities has been
realized.34 The social and economic consequences have been discussed
by many and are more often negative. 35 Professor Arti K. Rai states that
"the benefits of granting intellectual property rights in research are
significantly diminished by the losses in creativity and high transaction
costs that such grants generate and... norm-like mechanisms for
addressing transaction costs are unlikely to be successful. 36 However, it
has been historically noted, especially for the United States, that "[w]ith
a society secular in motive, dynamic in economy, scientific in
intellectual interest, it was inevitable that its political institutions should
reflect these dominant drives. 37
IV.

INSTITUTIONS: ACADEMIC AND INDUSTRY

Conflicts of interest exist throughout society and impact on any
discussion involving an issue as complex as stem cell research. Research
conflicts of interest have impacted society historically and both laws and
professional codes of ethics have attempted to improve the behavior of
those involved in discovery.38 The conflicts that researchers have include
conflicts between revealing the truth and seeking academic
advancement; between representing self and being the advocate/agent of
the research subject; and between loyalty to self, to institution, to
corporate sponsor, and to society. 39 Superimposed on these conflicts are
33. Pierre Azoulay et al., The Anatomy of Medical School Patenting, 357 NEw ENG. J. MED.
2049, 2052 (2007) ("The number of patents granted to medical school faculty increased from 122 in
1976 to 2175 in 2003 ....").
34. See DEREK BOK, UNIVERSITIES IN THE MARKETPLACE 75-76 (2003) (suggesting that the
commercialization of university research compromises the integrity of research conclusions and
increases the public's level of skepticism).
35. See Rai & Eisenberg, supra note 32, at 310 (arguing that while patents have allowed
universities to profit, they may actually restrict subsequent research and development). See
generally ADAM B. JAFFE & JOSH LERNER, INNOVATION AND ITS DISCONTENTS: How OUR BROKEN
PATENT SYSTEM IS ENDANGERING INNOVATION AND PROGRESS, AND WHAT TO Do ABOUT IT
(2004).

36. Arti Kaur Rai, Regulating Scientific Research: Intellectual PropertyRights and the Norms
of Science, 94 Nw. U. L. REV. 77, 121 (1999).
37. BURY, supra note 4, at xxxv.
38. See, e.g., CODE OF MED. ETHICS § 8.031 (Council on Ethical & Judicial Affairs, Am.
Med. Ass'n 2002).
39. See generally Robert Streiffer, Academic Freedom and Academic-Industry Relationships

in Biotechnology, 16 KENNEDY INST. ETHICS J. 129 (2006) (addressing concerns over the impact of
academic-industry relationships on academic freedom).
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those caused by institutional conflicts, such as when companies invest
financially in institutions or when institutions have a board of trustees
that represents both industry and the university or medical center. 40 The
ability of universities and medical centers to achieve monetary gains
from patents has been exaggerated and certainly has had unintended
pernicious consequences. 4 1 And these activities seem to have created a
potential for loss of social promises. Those promises relate to a covenant
between institutions of higher learning and society, where the
expectation is that the institutions of higher learning will have a primary
purpose of preserving and transferring knowledge and creating new
knowledge. The tacit understanding is that universities are not to become
businesses because society would suffer.4 2 Professor Yochai Benkler
points to several open access activities to demonstrate the benefits: for
example, the Massachusetts Institute of Technology's ("MIT's") Open
Courseware Initiative and the South African project, Free High School
Science Texts.43
Government offers another superimposed layer for conflicts.
Leaders of government may be influenced by special interest groups,
such that allocation of financial resources is effected. These outside
groups may include biotechnology companies, the pharmaceutical
industry, academia, or religious groups. Laws, such as the Bayh-Dole
Act 44 and the Stevenson-Wylder Act, 45 and policies, such as those

enacted under the Bush Administration,4 6 have had intended and
unintended consequences. The intent of law is to be just; however, when
political manipulation occurs, society suffers. The stem cell issues that
need resolution will be affected by these conflicts and require an
40. See Susan H. Ehringhaus et al., Responses of Medical Schools to InstitutionalConflicts of
Interest, 299 JAMA 665, 665 (2008); see also Annetine C. Gelijns & Samuel 0. Thier, Medical
Innovation and Institutional Interdependence: Rethinking University-Industry Connections, 287

JAMA 72, 72 (2002).
41.

See YOcHAI BENKLER, THE WEALTH OF NETWORKS: How SOCIAL PRODUCTION

TRANSFORMS MARKETS AND FREEDOM 339, 340 tbl.9.2 (2006); BOK, supranote 34, at 76-77.
42. See BENKLER, supra note 41, at 348.
43. Id.at 326-27.
44. University and Small Business Patent Procedures Act, 35 U.S.C. § 200-12 (2000).
45. Technology Innovation Act, 15 U.S.C. § 3710 (2006). The Federal Technology Transfer
Act of 1986 amended this Act and added to the government's desire to increase the
commercialization of research done in universities and national laboratories. Federal Technology
Transfer Act of 1986, Pub. L. No. 99-502, 100 Stat. 1785.
46. Press Release, George W. Bush, President Bush Discusses Stem Cell Veto and Executive
Order (June 20, 2007), available at http://georgewbush-whitehouse.archives.gov/news/releases/
2007/06/20070620-8.html. On March 9, 2009, President Obama issued an Executive Order that
addressed, and arguably eased, many of the restrictions imposed by President Bush. Exec. Order
No. 13,505, 74 Fed. Reg. 10,667 (Mar. 9, 2009).
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unraveling and subsequent alignment of interests that are morally
sound. 47 The Bayh-Dole Act and ensuing decisions in case law impacted
existing social norms of cooperation within academia and changed the
behavior of researchers to being more commercial-that is, more
secretive-and less academic. 48 Not all went along with the direction of
being pushed by government and industry; some universities resisted.
The contrast in behavior can be seen with gene patents, where the
researchers Georges K6hler and Cesar Milstein felt that it would be
ethically wrong for them to seek a patent, whereas Dr. Craig Venter
sought patents on thousands of gene fragments.49 MIT, Harvard, and
Stanford are attempting to show some restraint in seeking patents. °
Professor Rebecca Eisenberg points out that "the traditional American
conception of academic freedom is ill-suited to the task of protecting
academic values in externally sponsored research., 51 Rai further points
out that Eisenberg feels "progress in basic science occurs most quickly
not when it is coordinated by a single entity (such as a patent holder)
but, rather, when different teams of scientists, working independently
but with an awareness of each other's efforts, use divergent approaches
to the same problem., 52 This certainly is consistent with Benkler's views
and also philosopher Francis Fukuyama's view that decreased
trust
53
costs.
transactional
increases
communality)
(from diminished
V.

INTELLECTUAL PROPERTY AND PATENTS

A.

General

A basic ethical dilemma exists for society when considering
intellectual property and socially legal mechanisms for restricting the
use of knowledge. In the United States, Thomas Jefferson is the
47. See Mina Alikani, The Debate SurroundingHuman Embryonic Stem Cell Research in the
USA,

ETHICS,

BIOSCIENCE

&

LIFE,

Dec.

2007,

at

7,

7-10,

available

at

http://www.rbmronline.com/Article/3019; Baruch Brody, Intellectual Property and Biotechnology:
The U.S. !nternalExperience-PartI (pt. 1), 16 KENNEDY INST. ETHICS J. 1, 3, 12 (2006); Alan
Cribb et al., Towards the Applied: The Constructionof EthicalPositions in Stem Cell Translational
Research, 11 MED., HEALTH CARE & PHIL. 351, 359 (2008).
48. Rai, supranote 36, at 95-109.
49. Id. at 94, 98-99.
50. Id. at 112-13.

51. Rebecca S. Eisenberg, Academic Freedom and Academic Values in Sponsored Research,
66 TEx. L. REv. 1363, 1363 (1988).
52. Rai, supranote 36, at 124.
53. BENKLER, supra note 41, at 63; FRANCIS FUKUYAMA, TRUST: THE SOCIAL VIRTUES AND
THE CREATION OF PROSPERITY 351-52 (1995).

Published by Scholarly Commons at Hofstra Law, 2008

11

Hofstra Law Review, Vol. 37, Iss. 2 [2008], Art. 5
HOFSTRA LA W REVIEW

(Vol. 37:487

President who helped launch the patent system with specific ideas in
mind.
Jefferson wanted to encourage inventiveness and progress within the
context of a free-market economic system. At the same time, he
wanted inventions to benefit society ....To achieve [this], Jefferson
incorporated two critical features into patent law. First, a patent
provides the inventor with a form of ownership over the invention for a
limited time ....
Second, a patent is granted only if the inventor
reveals and describes the invention ....
The purpose of these features
of patent law was to ensure that "the public may have the full [free and
unrestrained)4 benefit [of the invention] after the expiration of the
patent term.
The opposite of legal intellectual property rights, such as patents, is the
concept of open access. 55 Benkler explores the ramifications of any
restriction to open access from a legal, economic, and cultural
perspective. He compares the industrial information economy that favors
strong protection of intellectual property with the networked information
economy that favors open access and no legal restrictions.56 He purports
that just a market-driven solution to intellectual property is not in the
best interest of the creation of knowledge.57 The multiple ways that
knowledge is created mandate an inclusive rather than an exclusive
system. Thus, laws should not create exclusive regulations that decrease
the dissemination of knowledge and therefore decrease the creation of
new knowledge.
This is especially critical at a major starting point of the creation of
knowledge, such as the institutions of higher learning. 58 Some of these
institutions have been "captured" by industry and function as agents of
industry rather than agents of society. 59 The problems with academicindustry relationships have received considerable attention. 60 Most are
concerned about its potential to diminish the societal functions of a
university. Others feel that technology transfer does the most social
54. LEE M. SILVER, CHALLENGING NATURE: THE CLASH OF SCIENCE AND SPIRITUALITY AT
THE NEW FRONTIERS OF LIFE 284 (2006).
55. BENKLER, supra note 41, at 60-61.

56. Id. at 1-5, 37-38.
57. Id.at 37-38.
58. Id.at 315.
59. See BOK, supra note 34, at 155-56 (noting that technology has made industry and science

inseparable).
60. See generally Ehringhaus et al., supra note 40 (providing the first comprehensive study of
institutional conflicts of interest in medical schools in the United States); Gelijns & Thier, supra
note 40 (discussing the interplay between medical inventions and industry).
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good, in that society may benefit from the works within institutions of
higher learning and national laboratories. 6 1 Thus, the Bayh-Dole Act and
the Stevenson-Wylder Act did much to encourage relationships between
academia and industry and caused an enormous increase in patenting
activity within universities and government laboratories. A result is that
the resources of institutions of higher learning-both public and
private-are being inappropriately utilized. "One concern relates to the
effects of increased academic patenting and licensing activity on the
values and culture of medical schools. 6 2 This becomes critical if
"scientists working at noncommercial research institutes funded by
nonprofit educational institutions and government grants produce most
of our basic science," 63 and such efforts produce knowledge that is
intended to sell something and make money. "The efficiency of
regulating information, knowledge, and cultural production through
strong copyright and patent is not only theoretically ambiguous, it also
lacks empirical basis. 64
Although this Article is not about the economic issues that relate to
intellectual property law, Benkler does note that "the reality of both
theory and empirics in the economics of intellectual property is that both
in theory and as far as empirical evidence shows, there is remarkably
little support in economics for regulating information, knowledge, and
cultural production through the tools of intellectual property law., 65 He
points to many successful business efforts that were accomplished
through open access.6 6 These include Linux (IBM), Slashdot, PLoS,
Wikipedia, and SETI@home.6 7 The power of the Internet is realized
with "commons-based peer production" that is based on "a new modality
of organizing production: radically decentralized, collaborative, and
nonproprietary; based on sharing resources and outputs among widely
distributed, loosely connected individuals who cooperate with each other
without relying on either market signals or managerial commands. 68
This description fits the description of perhaps an ideal but truthful
61. Cf George Elliott, Basics of US Patents and the Patent System, 9 AAPS J. E317, E317,
E319 (2007) (providing an overview of patents in the United States and describing patent
requirements); Gregory J. Glover, The Influence of Market Exclusivity on Drug Availability and
Medical Innovations, 9 AAPS J. E312, E312-13, E315 (2007) (discussing how patents and
ownership interests serve as incentives which promote innovation).
62. Azoulay et al., supranote 33, at 2050.
63. BENKLER, supra note 41, at 35.
64. Id.at 38.
65. Id.at 39.
66. Id. at 33, 46, 76, 82, 313.
67. Id.
68. Id.at 60.
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understanding that "[s]cience is built by many people contributing
incrementally-not operating on market signals, not being handed their
research marching orders by a boss-independently deciding what to
69
research, bringing their collaboration together, and creating science."
This type of collaboration was seen in the International HapMap Project
for mapping the human genome,7 ° which does not seem very different
from stem cell research. Benkler further elaborates on the cultural
values, such as freedom and health, of a cooperative society rather than a
totally commercialized society that successfully invades our institutions
of learning. 7'
It is also worth noting that the United States and Europe have
particularly strong intellectual property laws and that this has a negative
effect on the health of poorer countries. Sir Hugh Laddie, United
Kingdom High Court Patents Judge, stated that "[flor too long IPRs
[(intellectual property rights)] have been regarded as food for the rich
countries and poison for poor countries. 7 2 He hoped that new
government policy would change this.73 A more detailed look at the
patent system in the United States can be found in the works of Adam
Jaffe and Josh Lerner, who feel that a major problem resides in the
details of how the United States Patent and Trademark Office ("PTO")
functions. 74 "The undesirable manifestations of current policy can be
understood as the inevitable consequences of inventors, their attorneys,
and competing firms' exploitation of the incentives that changes in
policy and practice over the last two decades have inadvertently
created., 75 They also note that "[t]here are no easy solutions to the
problems of running a patent system. There is an inherent trade-off
[(ethical dilemma)] in this system, between rewarding innovators and
burdening commerce, competition, and other inventors. ,,76 They agree
with Benkler that there is a link between the economic incentives to

69. Id. at 63.
70. See International
visited Feb. 27, 2009).

HapMap Project, http://www.hapmap.org/thehapmap.html.en

(last

71.

BENKLER, supra note 41, at 14.
Hugh Laddie, Foreword to COMM'N ON INTELLECTUAL PROP. RIGHTS, EXECUTIVE
SUMMARY: INTEGRATING INTELLECTUAL PROPERTY RIGHTS AND DEVELOPMENT POLICY 7 (2002).

72.
73.

Id

74. JAFFE & LERNER, supra note 35, at 2.
75. ADAM B. JAFFE & JOSH LERNER, INNOVATION AND ITS DISCONTENTS: How OUR BROKEN
PATENT SYSTEM IS ENDANGERING INNOVATION AND PROGRESS, AND WHAT TO DO ABOUT IT, at xi
(3d ed. 2007) (2004).

76. JAFFE & LERNER, supra note 35, at 79.
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patent and the health of society." Jaffe and Lerner are both economists
and note that
[e]conomists have often been perceived as hostile to the patent system.
We do not consider ourselves anti-patent. We are just anti-bad patents,
and anti-blackmail made feasible by a court system stacked against
those who challenge the bad patents. We want a patent system that can
be presumed valid, because a valid patent system is vital to the
continued 78
health of innovation, and, hence, economic growth and
prosperity.
Thus, Jaffe and Lerner feel that the patent system is bad, but can be
fixed. Examples of the areas of the United States patent system that need
correction include: (1) industry-capture of the PTO due to the fees paid
to the PTO for the patent process and therefore the need for more
financial resources from government and not from industry so as to
reduce conflicts of interest (Does the PTO work for the public or for
industry?); (2) a court system (particularly the Court of Appeals for the
Federal Circuit) that favors industry and therefore the need for more
skilled judges and specially appointed masters "to decide technical
issues of novelty and obviousness"; and (3) pre-grant opposition (input
from the public) and effective reexamination. 79 Benkler feels that we
need a patent system that adheres to the concepts of freedom.8 ° More
information freedom would allow for a nonproprietary information
system to also flourish, such as increased open access to new
information that would allow society to benefit from both proprietary
and nonproprietary economic models.8 1 Professor Lee Silver also feels
that "[t]he larger the number of independent scientists working on a
problem--collaborating, competing, and exchanging information-the
faster progress is made., 82 Professor Baruch Brody offers additional
suggestions to modify patent laws so as to respect social values. 83 A new
method of peer review of patents using the Internet is being tried in the
United States and Europe, including the United Kingdom. This "peer to
patent" process hopes to address some of the concerns that exist with the
77. See BENKLER, supra note 41, at 310-12.
78. JAFFE & LERNER, supranote 35, at 207.
79. Id. at 206.
80. BENKLER, supra note 41, at 130.
81. Id.at 145-46.
82. SILVER, supranote 54, at 318-19.
83. Baruch Brody, Intellectual Property and Biotechnology: The U.S. Internal ExperiencePart H (pt. 2), 16 KENNEDY INST. ETHics J. 105, 125 (2006) (listing several recommendations,
including "limiting the patenting of research tools and/or... providing a research exception to
patent protection").
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present system, such as "prior art" assessment done only by one patent
office examiner with limited time and sometimes limited expertise. 4
Another concern with the proliferation of patents is the problem of the
"anticommons." An "anticommons" occurs "when multiple owners each
have a right to exclude others from a scarce resource and no one has an
effective privilege of use." 85 Thus, "more [intellectual property] rights
may lead paradoxically to fewer useful products for improving human
health. 86 The example below captures most of the bad that comes from
patenting new technology and the costs to academia and to society.8 7
B. Stem Cells
Over 8334 stem cell patents have been issued as of March 2009 by
the PTO.88 This will ineluctably lead to increased costs for research and
restriction of access to scientific information. Does society benefit from
this? The evolving story of Dr. James Thomson's discoveries and the
three patents sought by the Wisconsin Alumni Research Foundation
("WARF")89 hint at some of the potential problems with patenting of
stem cells. The public interest groups Public Patent Foundation and the
Foundation for Taxpayer and Consumer Rights challenged the validity
of the three WARF patents. 90 Dr. Thomson's work received private
funding from the Geron Corporation, which received exclusive
commercial rights to selective human embryonic stem cells. 9' Many
negative issues have been raised for a long time regarding the problems
that patents have caused. The economic consequences of protecting
84. See Beth Simone Noveck, "Peer to Patent": Collective Intelligence, Open Review, and
Patent Reform, 20 HARv. J.L. & TECH. 123, 144-45 (2006).
85. Michael A. Heller & Rebecca S. Eisenberg, Can Patents Deter Innovation? The
Anticommons in Biomedical Research, 280 SCIENCE 698, 698 (1998).
86. Id. at 701.
87. Aaron S. Kesselheim, Intellectual Property Policy in the PharmaceuticalSciences: The
Effect of InappropriatePatents and Market Exclusivity Extensions on the Health Care System, 9
AAPS J. E306, E307 (2007) (discussing how the growth of patents in the pharmaceutical industry
may have slowed innovation, rather than encouraging it); see also Adam D. Moore, Intellectual
Property, Innovation, and Social Progress. The Case Against Incentive Based Arguments, 26
HAMLINE L. REv. 602, 610-14 (2003) (arguing that the current incentive-based system for
innovation is ineffective).
88. U.S. Patent and Trademark Office, http://patft.uspto.gov (follow "Quick Search"
hyperlink; then run Query "stem cell") (last visited Mar. 24, 2009).
89. Brody, supra note 83, at 122.
90. Public Patent Foundation, Activities, http://www.pubpat.org/warfstemcell.htm (last visited
Feb. 28, 2009).
91. Brody, supra note 83, at 122; see also Joseph Itskovitz et al., Wisconsin Scientists Culture
Elusive Embryonic Stem Cells, SCIENCEDAILY, Nov. 6, 1998, http://www.sciencedaily.com/
releases/998/11/981109085437.htn.
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intellectual property with patents are different than those resulting from
protecting physical property. This has to do with the original economic
concepts surrounding patents. The Thomson patents allow WARF to
mandate money from anyone who wants to use their stem cells, thus
increasing the cost of research and restricting the research to only those
who can afford to pay.92 It should be noted that different financial
arrangements have been made to accommodate the furor over the broad
reach and financial impact of these patents. This accommodation was
primarily for research to be done in universities or national laboratories.
The effect has not been assessed as it is still too early, but many are still
upset with the extent of the patents.
These patents also restrict research because of the increased costs
associated with obtaining patents, per primum; again, this economically
disenfranchises the poorer university or country.93 It may also lead to
research that seeks exclusive patents so as to satisfy the corporate
sponsor and to increase secrecy. "Property rights can limit the
distribution of intellectual property and can draw excessive resources
into the creation of intellectual property, and away from other socially
valuable activities, by the phenomenon of rent seeking." 94 However, as
far as the WARF patents, the issue of patent continuation has yet to be
resolved in the courts. 95 Professor Russell Korobkin takes another look
at the WARF patents and expresses concern over the impact on the
broad nature of the patents and the ability of WARF to seek a "$100,000
up-front fee and a $25,000 annual maintenance fee from companies
wishing to buy commercial licenses., 96 He then clarifies the separation
of patents and intellectual property created with public funding and the
need to commercialize new discoveries so that society may benefit.
While patent rights are necessary to encourage socially beneficial
scientific research, the need is reduced when public funding
underwrites the costs of innovation.... In this situation, the incentive
of patent protection is unnecessary to encourage the production of
basic science, but it remains necessary to encourage private industry to
invest .... Both the federal Bayh-Dole Act and CIRM's intellectual
property policies are inattentive to this subtlety because they allow
92. Id.at 123.
93. See Laddie, supra note 72, at 7.
94. Richard A. Posner, The Law and Economics of Intellectual Property, in I INTELLECTUAL
PROPERTY RIGHTS: CRITICAL CONCEPTS IN LAW 157, 165 (David Vaver ed., 2006).

95. See Katja Triller Vrtovec & Christopher Thomas Scott, PatentingPluripotence: The Next
Battlefor Stem Cell Intellectual Property,26 NATURE BIOTECHNOLOGY 393 (2008).
96.

RUSSELL KOROBKIN, STEM CELL CENTURY: LAW AND POLICY FOR A BREAKTHROUGH

TECHNOLOGY 97 (2007).
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grantees to patent all government-funded inventions, rather than just

the types of inventions for which the 97
incentive is necessary to assure
that the innovation reaches the market.
In addition, the patents to date have
not resolved the critical question as
98
to the definition of pluripotency.
The federal restrictions in the United States on funding for stem cell
research have led to states creating funding mechanisms for stem cell
research in a very inconsistent and perhaps economically costly manner.
California, New York, and other states have formed entities that have
been funded with taxpayer monies, ($3 billion for California and $660
million for New York). 99 To deal with these complex issues, newly
formed government agencies had to be established; in California, it is
the California Institute for Regenerative Medicine ("CIRM") and in New
York, it is the Empire State Stem Cell Board ("ESSC").10 0 Some view
this as positive, although with some reservations, and warn that:
Bioethicists are often interested mostly in national standards and
institutions, but state governments have historically overseen a wide
range of bioethical issues and share responsibility with the federal
government for still others. States ought to have an important role. By
allowing for multiple outcomes, the American federal
10 system allows a
better fit between public opinion and public policies. 1
They further encourage that an "[a]wareness of the decentralized and
complicated institutional and political machinery that governs bioethical
decision-making in this country would make bioethical discussions more
immediately relevant to public debates about these issues."' 10 2 In
addition, differences in patent practices between the United States and
European countries further complicate related issues, such as economics,
politics, and religion. The European Patent Office ("EPO"), through
their Opposition Division ("OD"),
97. Id.at260-61.
98. Vrtovec & Scott, supra note 95, at 393-94.
99. Press Release, N.Y. State Dep't of Health, New York's Stem Cell Research Strategic Plan
Available for Public Comment: Will Guide New York's 11 -Year, $600 Million Investment (May
28, 2008), available at http://www.nyhealth.gov/press/releases/2008/2008-05-28_stem-cell
strategic_plan.htm; CIRM, supra note 26.
100. CIRM, supra note 26; NYSTEM, supra note 26; see also CAL. COUNCIL ON SCI. & TECH.
INTELLECTUAL PROP. STUDY GROUP, POLICY FRAMEWORK FOR INTELLECTUAL PROPERTY
DERIVED FROM STATE-FUNDED RESEARCH: FINAL REPORT TO THE CALIFORNIA LEGISLATURE AND
GOVERNOR
OF
THE
STATE
OF
CALIFORNIA
7
(2006),
available
at
http://www.ccst.us/publications/2006/IPFinalES.pdf.
101. Fossett et al., supra note 27, at 24.
102. Id. at 34.
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held that the [human embryonic stem cell] patent contravened a rule
that had been transposed directly from Article 6(2)(c), namely, the
prohibition on "uses of human embryos for industrial or commercial
purpose." Even in the absence of a uniform moral approach to human
ES cells in Europe, the OD reasoned that the rule ". . . has to be
interpreted broadly to encompass not only the industrial or commercial
use of human embryos but also the 1human
ES cells retrieved therefrom
03
by destruction of human embryos."'
VI.

RESOLVING ETHICAL DILEMMAS AND CONFLICTS OF INTEREST

The premise of this Article is that values lie at the foundation of the
stem cell debate. These values emanate from science, medicine, and
religion. A strategy for gaining consensus exists if we can combine
pluralism and particularism, as Wallace has proposed:
The views that values are irreducibly plural and sometimes
incompatible (pluralism) and that attention to the concrete
circumstances
in
which
practical
problems
arise
is
necessary... (particularism) indicate a certain understanding of
practical knowledge. On the latter view, such knowledge consists in an
accumulation of ways of solving problems that experience has shown
to be better rather than worse for certain purposes
.... Such practical
14
knowledge includes matters classified as moral. 0
The many ways that disagreements have been solved within and between
societies have included: (1) merely adapting to progress, either social or
scientific; (2) creating new social mores; and (3) creating new laws and,
occasionally, war.
The principles and rules of law that exist in a pluralistic world are
challenged when new technology emerges.
What one should do in concrete situations in which such
considerations conflict ...is to seek a way to modify the principles in
such a way that (1) one can observe them both, (2) the roles, that is, the
103. Aurora Plomer et al., Commentary, Challenges to Human Embryonic Stem Cell Patents,2
CELL STEM CELL 13, 15 (2008). See generally R. Stephen Crespi, Patentingand Ethics-A Dubious
Connection, 85 J. PAT. & TRADEMARK OFF. Soc'Y 31 (2003). He notes that the European Patent
Convention Article 53(a) "excludes from patentability any invention 'the publication or exploitation
of which is contrary to morality or ordre public."' Id.at 32. He also finds that the European Group
of Ethical Advisers to the European Commission has "side-stepped the most difficult questions and
has settled for devising its own patentability criteria, of which the key opinion is that only stem cells
that have been modified by in vitro treatment or genetic modification can be considered fit subject
matter for patents." Id.at 47.
104. JAMES D. WALLACE, ETHICAL NORMS, PARTICULAR CASES 7-8 (1996).
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purposes of the principles in the activity at hand are preserved,10and
5 (3)
the modification occasions a minimum of disruption elsewhere.
This has occurred to some degree with advances in reproductive
technology, birth control pills, and in vitro fertilization. Although these
suggestions are helpful, the issues at hand, such as the definition of
when life begins and sanctity of life and the disparate views held by a
minority, mandate a level of moral analysis that must accept that "[t]here
is a powerful intellectual temptation to suppose that morality consists in
a body of principles or rules that unambiguously indicate the right thing
to do in every circumstance.' 0 6 What will be required is for leaders who
represent entities, both religious and non-religious, to come together
and, through extensive dialogue, to reach consensus that allows for
respect of the pluralistic constituencies and social progress. "Whether
this happens, however, depends upon the richness of their practical
knowledge,10 7their ingenuity and courage, and the difficulty of the
problems."'
A.

Religious

The religious debate over stem cell research revolves around the
definition(s) of life and when it begins. This Article does not deal with
these issues in any great detail; however, the relationship of knowledge
and religion is worth noting. It is stated in Ecclesiastes 1:18: "For in
much wisdom is much grief: and he that increaseth knowledge
increaseth sorrow."' 08 However, progress in some religious philosophies
seems to allow an appreciation of the lack of conflict between scientific
progress and religion. Francis Bacon also notes in his early essays
(written in approximately 1589) that religious concerns were still
present: "that the aspiring to overmuch knowledge was the original
temptation and sin whereupon ensued the fall of man: that knowledge
hath in it somewhat of the serpent, and therefore where it entereth into a
man it makes him swell."' 1 9 Bacon cites Solomon's censure, "'[t]hat
there is no end of making books, and that much reading is weariness of
the flesh,"' and "'[t]hat in spacious knowledge there is much
contristation [(sadness)], and that he that increaseth knowledge

105. Id.at20.
106. Id.at21.

107. Id.at 45.
108. Ecclesiastes 1:18 (King James).
109.

FRANCIS BACON, THE ADVANCEMENT

OF LEARNING AND NEW ATLANTIS 6 (Arthur

Johnston ed., 1974).

https://scholarlycommons.law.hofstra.edu/hlr/vol37/iss2/5

20

Packer: Embryonic Stem Cells, Intellectual Property, and Patents: Ethical
20081

STEM CELLS, INTELLECTUAL PROPERTY, AND PATENTS

increaseth anxiety.-' ' l 0 St. Paul, in Colossians 2:8, gives another caveat
cited by Bacon: "Beware lest any man spoil you through philosophy and
vain deceit, after the tradition of men, after the rudiments of the world,
and not after Christ.""' Bacon states that "experience demonstrates how
learned men have been arch-heretics, how learned times have been
inclined to atheism, and how the contemplation of second causes doth
' 12
derogate from our dependence upon God, who is the first cause.,
Bacon then proceeds to plead the case that science is not against religion
and is a benefit to society.
These same religious fears regarding science-here stem cell
research-continue. Professor Prieur and his co-authors state: "Catholic
teaching permits neither the creation nor the destruction of human
embryos for the purposes of research. However, stem cell lines derived
from human embryonic tissue now exist and research currently is being
done in some centers using these cell lines." ' 1 3 The authors continue
with a religious caution:
Science also could be on the verge of a spectacular disaster by
tampering with the core essentials of human life and its reproduction at
the genetic and cellular level. This tension exists in a culture that
values efficiency, haste, technology, and expediency, often at the
expense of other values such as the dignity of the human person,
respect for the mystery of life, human limitations including death, and,
ultimately, the plan of the Creator.114
One could be concerned that not much has changed. This debate has
been further updated in the recent writings of scholars D.W. Brock,' 15
Jan Deckers,116 Mina Alikani," 7 and others. The exact definition of
embryo remains a problem, although several authors have tried to
address this issue with some of the recent scientific discoveries
considered. Researcher David de Kretser states,
However, I have no doubt that techniques will become available to
remove the need for human eggs to make the induced pluripotent stem

110. Id. (quoting Ecclesiastes 1:18, 12:12).
111. Colossians2:8 (King James).
112. BACON, supra note 109, at 6.
113. Prieur et al., supra note 23, at 74.
114. Id. at 73.
115. D.W. Brock, Is a Consensus Possible on Stem Cell Research? Moral and Political
Obstacles,32 J. MED. ETHICS 36, 36 (2006).
116. Jan Deckers, Are Those Who Subscribe to the View That Early Embryos Are Persons
Irrationaland Inconsistent?A Reply to Brock, 33 J. MED. ETHICs 102, 103-06 (2007).
117. Alikani, supranote 47, at 7-10.
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cells from adult human cells. This will further remove the ethical
dilemmas, since if eggs or zygotes are not used, the collection of
induced pluripotent stem cells cannot progress to form an embryo or
implant into the uterus since these cells do not have the capacity to
form a placenta.
...

Even if there is a small chance of these pluripotent cells giving

rise to an embryo, it would be difficult to argue that any or indeed
every adult cell should be given the status of a potential
embryo .... 118

However, recent scientific research has shown that new techniques such
as retro-engineering allow skin cells to attain embryo-like potential and
altered nuclear transfer may help to answer some, but not all, of the
religious concerns. " 9
B. Conflicts of Interestfor Academia and Industry
An improved, more respectful, socially responsible relationship is
needed between academia and industry. Society will not prosper if the
social purposes of universities and government laboratories are not
fulfilled because resources are diverted for market profits and not for
social benefits. Similarly, a better balance is needed regarding
commercialization of knowledge. It is not always the best for society to
have restrictions to access of new knowledge. Society has witnessed the
pharmaceutical industry preferentially seek out profit-making drugs,
such as Viagra. 120 They have a fiduciary responsibility to stockholders to
do just that and no stockholder would accept diminished financial return
so that the company could do more socially responsible research. This
may well happen with stem cell research, if it becomes "Viagrified"; that
is, preferentially focuses on treatments to improve performance,
appearance, etc. We need to resolve the dilemma that commercialization
now presents to academia. Former President of Harvard University
Derek Bok points out the negative effects that commercialization has
had on that institution, and it is likely to be similar at other institutions of

118. David de Kretser, Totipotent, Pluripotentor Unipotent Stem Cells: A Complex Regulatory
Enigma and FascinatingBiology, 15 J.L. & MED. 212, 216 (2007).

119. See William B. Hurlbut, Ethics and Embryonic Stem Cell Research: Altered Nuclear
Transfer as a Way Forward,21 BIODRUGS 79, 80 (2007); Insoo Hyun, Stem Cellsfrom Skin Cells:
The Ethical Questions, 38 HASTINGS CENTER REP. 20, 21-22 (2008); Vrtovec & Scott, supra note

95, at 393-94.
120.

Richard A. Castellano, Patent Law for New Medical Uses of Known Compounds and

Pfizer's Viagra Patent,46 IDEA: INTELL. PROP. L. REv. 283, 288 (2006).
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higher learning. 12 ' The marketplace is not the solution for every social
need, and society, through political action, must represent the entire
citizenry and not just the powerful interest groups, such as the biotech
and pharmaceutical industries. These industries will continue to apply all
legal means to gain profitable positions in the potential
commercialization of products from stem cell research.
C. The Law andSociety
Recently, changes have been suggested that revolve around patent
122
law, the PTO, and its procedures, as well as changes in social norms.
Rai prefers a solution that includes both changes in the law and changes
in social norms of behavior.123 This might lead to more appropriate use
of patents and improve relationships between academia and industry, if
both accept these changes. He emphasizes, as does Wallace, 24 the
25
importance of being pragmatic and dealing with particulars.
Bioethicist David Resnik offers specific suggestions as to how to deal
with stem cells patents. These include eight suggestions regarding
property rights, such as, "[i]t should be legal to patent ES cells, products,
and related technologies.... [but] [p]atents on ES cells, products, and
related technologies should not be excessively broad."'126 Donald
Willison and Stuart MacLeod point out that an Ontario report on
genetics, testing, and gene patenting suggested several changes to
Canadian law. 27 European law differs significantly from United States
law regarding embryonic stem cell research and patents. Article 6(2)(c)
of the European Patent Convention states that "'uses of human embryos
for industrial or commercial purposes'
is not permitted to be
patented. 28 Professor Joseph Stiglitz suggests a medical prize fund,
which might allow monies for more socially 129important research as
opposed to more commercially suitable research.

121. BOK, supranote 34, at 199-205.
122. See JAFFE & LERNER, supra note 35, at 170-207; Rai, supranote 36, at 137-44.
123. Rai, supra note 36, at 144-51.
124.

WALLACE, supra note 104, at 7-8.

125. Rai, supranote 36, at 152.
126. David B. Resnik, The Commercializationof Human Stem Cells: Ethical and Policy Issues,
10 HEALTH CARE ANALYSIS 127, 151-52 (2002).

127. Donald J. Willison & Stuart M. MacLeod, Patentingof Genetic Material:Are the Benefits
to Society Being Realized?, 167 CAN. MED. ASS'N J. 259, 261 (2002).
128. Plomer et al., supranote 103, at 15 (footnote omitted).
129. Joseph E. Stiglitz, Scrooge and Intellectual PropertyRights: A Medical Prize FundCould
Improve the Financing of Drug Innovations, 333 BMJ 1279, 1279-80 (2006); see also S. 2210,
110th Cong. § 3 (2007) (Bill providing for the establishment of a Medical Innovation Prize Fund).
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ETHICAL ALIGNMENT

A.

Freedoms

Ethical alignment is more simply dealt with by eliminating some
ethical views. For instance, the possibility of viewing healthcare law as
mainly an issue of consumerism would obviate complex analysis.
However, health is at the core of "what makes a life livable"1' 30 and can
be realized in its centrality to the Human Development Index ("HDI").
"The HDI tries to capture the capacity of people to live long and healthy
lives... ,,31 In addition, there is a need for international alignment
from a legal and moral perspective. Each nation state may develop laws
that have unintended consequences and represent narrow views and
limited philosophical underpinning. As noted by Dr. Henk ten Have:
"This [neutral] language [of bioethics] seems itself to represent the
specific moral language of a specific moral community, particularly
the (neo) liberal community with universal and equal respect and selfdetermining freedom as its hypergoods. Upon analysis, bioethics is
apparently itself the cultural expression of the political norms of
liberalism13 2 and individualism, characteristic of North American
society."

Ethical alignment should extend beyond geographic borders. Also,
understanding the many loci of decisionmaking within each society
becomes essential if a dialogue is to be meaningful. 33 Religious groups
and secular players represent sources of political influence through
lobbying and political contributions. Other pressure groups include
businesses that seek to profit from new technology and universities and
government laboratories performing basic research and seeking financial
interest through patents and protection of intellectual property. Finally,
one must ask who along this long line of stakeholders represents society
and has the wisdom to make choices that benefit society.
Where does good public policy emanate from? The need for "smart
regulators" represents a point of view that is not respected by many and
the need to understand the role of actions by government other than
regulations requires better understanding. Scientific progress that is

130.

BENKLER, supra note 41, at 309.

131. Id. at310.
132. Morgan, supra note 20, at 80 (footnote omitted) (quoting Dr. ten Have).
133. Stephen A. Erickson, Forewordto GLOBAL BIOETHICS: THE COLLAPSE OF CONSENSUS, at
vii, vii-xii (H. Tristram Engelhardt, Jr. ed., 2006).
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supported by government-that is, taxpayer money-deserves
accountability; but the question is whether the government merely
represents an aggregate view of commercial interests without an
ethically principled interpretation of its actions. The United States
government, through the National Academy of Sciences, has initiated an
effort to address some of the social concerns with the formation of the
134
Committee on Guidelines for Human Embryonic Stem Cell Research.
If the benefits of stem cell research are limited because patents reduce
the potential of poorer populations from gaining access to its benefits,
we will have further fragmentation of the world.
B. Religion
The divergent religious views have created varying views of stem
cell research. Disagreement exists over fundamental beliefs of the
definition of life and when it begins, the definition of a soul, issues of
afterlife, and concepts of the cycle of life. This is seen in the different
views of the world's religions. Some have very different views of
afterlife or the lack of it, and thus the answers to questions about the
beginning and end of life may vary. 135 Silver states that "[c]ommunal
codification of spiritual beliefs is one definition of religion. So to
understand the relationship between spirituality and science, we must
understand religion in all its various guises.' 36 He also notes that there
are over 10,000 individual religions, with Christianity having 33,830
denominations. 137 In the United States, the intermingling of religion and
politics came to the surface with the President's Council on Bioethics.
Former Chair Leon Kass championed the mysteries of religion and the
sanctity of life as reasons for not funding embryonic stem cell
have written to confront his view as being wrong from
research.138 Many 139
many viewpoints.

134.

NAT'L RESEARCH COUNCIL & INST. OF MED., GUIDELINES FOR HUMAN EMBRYONIC

STEM CELL RESEARCH 3 (2005), available at http://www.nap.edu/catalog/l1278.html.
135. See id.at 47-49 (noting that Islam, Judaism, and some Protestant denominations "do not
recognize the human embryo before 40 days after conception as an entity that should be accorded
the same moral status as a person").
136. SILVER, supranote 54, at 19.
137. Id.
138. See generally Kass, supra note 16 (asserting that scientific advances in the realm of stem
cell research is a threat to traditional religious values).
139. See, e.g., SILVER, supra note 54, at 54-55; DeGrazia, supra note 18, at 56.
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C. Respecting CriticalMoral Values in a PluralisticSociety and
PreservingDemocracy
From a philosophical view:
[W]e must give up "the... hope that somehow, somewhere, a magic
philosophical formula will be devised that will enable serious
philosophical minds to pierce, once and for all, the fog of indecision
that attends ampliative governance when it is engaged with norms that
broadly and deeply give form to our life and thought. The agitation,
suffered, not
doubt, indecision, controversy, etc., are not ailments
140
symptoms of disease, but normally signs of health."'
The divergent views can be seen in the articles by Brock 14 1 and
Deckers,142 as well as Professors Bonnie Steinbock 143 and David
DeGrazia, 144 over embryos and personhood. As noted with reproductive
potential, the philosophical debate will not always allow all parties to
agree, and it is necessary to respect all views if a consensus is to be
reached.
The question is how we approach solving the complex issues raised
by stem cell research and its potential applications. I propose that a
sociological view of values may allow for dialogue that bridges some of
the differences and may allow for consensus. Jonathan Haidt and Jesse
Graham present just such a view. 14 5 They have proposed a "social
intuitionist" model for the different moral views that exist in the
world. 146 This work is built on and extends the works of Lawrence
Kohlberg, 147 Carol Gilligan, 148 and Richard Shweder and his

140. WALLACE, supra note 104, at 162-63 (footnote omitted) (quoting Frederick L. Will).
141. See generally Brock, supra note 115 (rejecting both the moral and political arguments
against human embryonic stem cell research).
142. See generally Deckers, supra note 116 (responding to Brock's claims regarding the status
of human embryos).
143. See generally Bonnie Steinbock, The Morality of Killing Human Embryos, 34 J.L. MED.
& ETHICS 26, 34 (2006) ("[lI]t is permissible to use human embryos in research that kills them
because embryos lack moral status.").
144. See generally DeGrazia, supra note 18 (concluding that the Bush Administration's
opposition to cloning and embryonic stem cell research was incorrect).
145. Jonathan Haidt & Jesse Graham, When Morality Opposes Justice: Conservatives Have
Moral Intuitions That Liberals May Not Recognize, 20 SOC. JUST. RES. 98, 111 (2007).
146. Id.at 100.
147. See generally LAWRENCE KOHLBERG, 2 ESSAYS ON MORAL DEVELOPMENT: THE

PSYCHOLOGY OF MORAL DEVELOPMENT 1 (1984) (theorizing on the development of moral
judgment).
148.

See generally CAROL GILLIGAN, IN A DIFFERENT VOICE: PSYCHOLOGICAL THEORY AND

WOMEN'S DEVELOPMENT (1982) (reporting research that "provide[s], in the field of human
development, a clearer representation of women's development").
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coauthors.1 49 Shweder has three areas for his moral discourse: the ethics
of autonomy, community, and divinity.' 50 The five psychological
systems for moral evaluation that Haidt and Graham include are: (1)
(4)
(3) ingroup/loyalty;
fairness/reciprocity;
(2)
harm/care;
151
authority/respect; and (5) purity/sanctity.
The harm/care dyad evolved from the Kohlberg-Gilligan debates
that related to early moral education (gender differences) and has
professionalism. 52
and
healthcare
to
connection
obvious
Fairness/reciprocity represents the second value system that liberals
view as essential in a "good" society.' 53 The last three value systems are
critical to the stem cell "wars" as they represent the value systems of
religious groups and political conservatives. 154 Haidt and Graham note
that the five foundation theory "offers a surprisingly simple explanation
of the 'culture war' going on in the United States, and in other
democracies."'' 55 For ethical alignment to occur so as to move stem cell
research forward more effectively, all parties will benefit from
recognizing all of the five moral foundations so that we "can open up a
door in the wall that separates liberals and conservatives when they try
to discuss moral issues."' 56 This will not be easy: "[m]obility and
diversity make a morality based on shared valuation of traditions and
institutions quite difficult.' 57 Haidt and Graham perhaps ignore political
correctness when they divide the foundational values into tribal and nontribal.' 58 The former are harms and fairness, and the latter include
loyalty, authority and respect, and purity. Defining principles alone is
not likely to lead to consensus. This occurred when an attempt was made
to establish a global bioethics. A major reason for the failure was the
differences between the secular and the religious views. 59 Haidt and
Graham's values point out the dichotomy of values between tribal and

149.

Richard A. Shweder et al., The "Big Three" of Morality (Autonomy, Community, Divinity)

and the "Big Three" Explanations of Suffering, in MORALITY AND HEALTH 128, 129 (Allan M.

Brandt & Paul Rozin eds., 1997).
150. Id.
151. Haidt & Graham, supra note 145, at 99.
152. Id.at 100-01.
153. Id. at 104-05.
154. Id at 105-06.
155. Id. at 107.
156. Id.at 113.
157.

Id.

158. Id. at 102. Haidt and Graham use the phrase "ethic of community," which encompasses "a
collection of institutions, families, tribes, guilds or other groups." Id.
159. H. Tristam Engelhardt, Jr., Global Bioethics: An Introduction to the Collapse of
Consensus, in GLOBAL BIOETHICS: THE COLLAPSE OF CONSENSUS, supra note 133, at 1, 15-17.
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non-tribal groups. The former preferentially value loyalty,
authority/respect, and purity over harm and fairness, and the latter do the
opposite. 160 As noted above, this can be seen in moral decisionmaking
when one compares political liberals and conservatives. And certainly
this is worth considering in solving some of the differences in the world
that are clearly more than just political. It should be pointed out that all
potentially important variables are not discussed here. For instance,
moral evaluation skills were at first not thought to be influenced by
gender and were later found to be a critical variable. 16 1 Thus, other
variables, such as age, education, and geography, may be important.
Therefore, any conversation concerning stem cell research must begin
62
with principles, but quickly look for common ground in particulars'
that may be facilitated by discussing the values in a nonjudgmental
manner. And this will occur "only if science, religion, and politics can
find common ground.' ' 163 Science needs to exist with intellectual
freedom and integrity, divergent religious views need to be considered,
respected, and integrated into the policies of a democratic society, and
the political system (executive, judicial and legislative branches) has to
act to create laws and regulations that are "calibrated"' 164 so as to be
appropriate for the complex issues raised with innovative science. This
is certainly not meant to exclude other
efforts to deal with the divergent
65
views regarding stem cell research. 1

VII.

CONCLUSION

This Article has focused on the ethical issues surrounding stem cell
research. They have involved the areas of social values and norms,
society's views of science, technology, and progress, and the social
responsibility that institutions, such as universities, have to society as
compared to the institutions that are market-driven. These impact
knowledge, science, and progress. The ethical dilemmas and conflicts of
interest are discussed but emphasis is placed on the need for ethical as
well as economic alignment of all stakeholders.
Finally, a proposal for understanding the moral differences is given
based on the works of Haidt and Graham and others. The need to have
an understanding of the different moral values of participants in the stem
160. Id. at 104-05.
161.
162.
163.

See GILLIGAN, supra note 148, at 2; KOHLBERG, supra note 147, at 349.
WALLACE, supra note 104, at 7-8.
SILVER, supra note 54, at 130.

164. KOROBKIN, supranote 96, at 261.
165. See Cribb et al., supra note 47, at 359.
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cell "wars" is emphasized in that it may facilitate bridging a moral
divide and enable a consensus that will benefit society.
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